These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8642255)

  • 1. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen.
    Wang RF; Parkhurst MR; Kawakami Y; Robbins PF; Rosenberg SA
    J Exp Med; 1996 Mar; 183(3):1131-40. PubMed ID: 8642255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes.
    Wang RF; Appella E; Kawakami Y; Kang X; Rosenberg SA
    J Exp Med; 1996 Dec; 184(6):2207-16. PubMed ID: 8976176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames.
    Wang RF; Johnston SL; Zeng G; Topalian SL; Schwartzentruber DJ; Rosenberg SA
    J Immunol; 1998 Oct; 161(7):3598-606. PubMed ID: 9759882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes.
    Probst-Kepper M; Stroobant V; Kridel R; Gaugler B; Landry C; Brasseur F; Cosyns JP; Weynand B; Boon T; Van Den Eynde BJ
    J Exp Med; 2001 May; 193(10):1189-98. PubMed ID: 11369790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes.
    Wang RF; Robbins PF; Kawakami Y; Kang XQ; Rosenberg SA
    J Exp Med; 1995 Feb; 181(2):799-804. PubMed ID: 7836932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells.
    Mukherji B; Chakraborty NG; Yamasaki S; Okino T; Yamase H; Sporn JR; Kurtzman SK; Ergin MT; Ozols J; Meehan J
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8078-82. PubMed ID: 7644541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
    Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes.
    Robbins PF; el-Gamil M; Li YF; Topalian SL; Rivoltini L; Sakaguchi K; Appella E; Kawakami Y; Rosenberg SA
    J Immunol; 1995 Jun; 154(11):5944-50. PubMed ID: 7751637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.
    Kawakami Y; Eliyahu S; Delgado CH; Robbins PF; Sakaguchi K; Appella E; Yannelli JR; Adema GJ; Miki T; Rosenberg SA
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6458-62. PubMed ID: 8022805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of BING-4 cancer antigen translated from an alternative open reading frame of a gene in the extended MHC class II region using lymphocytes from a patient with a durable complete regression following immunotherapy.
    Rosenberg SA; Tong-On P; Li Y; Riley JP; El-Gamil M; Parkhurst MR; Robbins PF
    J Immunol; 2002 Mar; 168(5):2402-7. PubMed ID: 11859131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ.
    Ronsin C; Chung-Scott V; Poullion I; Aknouche N; Gaudin C; Triebel F
    J Immunol; 1999 Jul; 163(1):483-90. PubMed ID: 10384152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.
    Topalian SL; Rivoltini L; Mancini M; Markus NR; Robbins PF; Kawakami Y; Rosenberg SA
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9461-5. PubMed ID: 7937789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene.
    Guilloux Y; Lucas S; Brichard VG; Van Pel A; Viret C; De Plaen E; Brasseur F; Lethé B; Jotereau F; Boon T
    J Exp Med; 1996 Mar; 183(3):1173-83. PubMed ID: 8642259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
    Cole DJ; Wilson MC; Rivoltini L; Custer M; Nishimura MI
    Cancer Res; 1997 Dec; 57(23):5320-7. PubMed ID: 9393756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.
    Robbins PF; El-Gamil M; Li YF; Kawakami Y; Loftus D; Appella E; Rosenberg SA
    J Exp Med; 1996 Mar; 183(3):1185-92. PubMed ID: 8642260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage.
    Lupetti R; Pisarra P; Verrecchia A; Farina C; Nicolini G; Anichini A; Bordignon C; Sensi M; Parmiani G; Traversari C
    J Exp Med; 1998 Sep; 188(6):1005-16. PubMed ID: 9743519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.
    Van den Eynde B; Peeters O; De Backer O; Gaugler B; Lucas S; Boon T
    J Exp Med; 1995 Sep; 182(3):689-98. PubMed ID: 7544395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells.
    Wang RF; Wang X; Rosenberg SA
    J Exp Med; 1999 May; 189(10):1659-68. PubMed ID: 10330445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.
    Rivoltini L; Kawakami Y; Sakaguchi K; Southwood S; Sette A; Robbins PF; Marincola FM; Salgaller ML; Yannelli JR; Appella E
    J Immunol; 1995 Mar; 154(5):2257-65. PubMed ID: 7868898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes.
    Robbins PF; El-Gamil M; Li YF; Fitzgerald EB; Kawakami Y; Rosenberg SA
    J Immunol; 1997 Jul; 159(1):303-8. PubMed ID: 9200467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.